NYSE:STESteris Stock Price, Forecast & News

Steris' stock was trading at $145.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, STE stock has increased by 6.2% and is now trading at $154.28. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Steris.

Steris PLC (NYSE:STE) issued its earnings results on Wednesday, May, 13th. The medical equipment provider reported $1.64 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.07. The medical equipment provider earned $822.99 million during the quarter, compared to the consensus estimate of $788.37 million. Steris had a net margin of 13.45% and a return on equity of 16.34%. During the same period last year, the company posted $1.53 earnings per share. View Steris' earnings history.

Steris announced a quarterly dividend on Wednesday, May 13th. Shareholders of record on Friday, June 12th will be given a dividend of $0.37 per share on Friday, June 26th. This represents a $1.48 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend is Thursday, June 11th. View Steris' dividend history.

3 analysts have issued 12 month price objectives for Steris' stock. Their forecasts range from $170.00 to $170.00. On average, they expect Steris' share price to reach $170.00 in the next year. This suggests a possible upside of 10.2% from the stock's current price. View analysts' price targets for Steris.

News stories about STE stock have trended very negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Steris earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Steris.

Steris saw a increase in short interest in June. As of June 15th, there was short interest totaling 1,360,000 shares, an increase of 7.1% from the May 31st total of 1,270,000 shares. Based on an average daily volume of 736,000 shares, the short-interest ratio is presently 1.8 days. Approximately 1.6% of the shares of the stock are sold short. View Steris' Current Options Chain.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Masimo (MASI) and Insulet (PODD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Home Depot (HD), Mastercard (MA), AT&T (T), Abbott Laboratories (ABT), Cisco Systems (CSCO), Gilead Sciences (GILD) and Mcdonald's (MCD).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Park National Corp OH (0.00%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View institutional ownership trends for Steris.

STE stock was purchased by a variety of institutional investors in the last quarter, including Park National Corp OH. View insider buying and selling activity for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $154.28.

Steris has a market capitalization of $13.11 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

The official website for Steris is www.steris.com.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]